ESR2 and prostate carcinoma: In accordance with this notion, target gene studies reveal that ERα and ERβ may have distinct biological functions; it is believed that ERα promotes cell growth, while ERβ inhibits it in breast and prostate cancer cells [11], [14], [16], [17], [18], [19].